Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT

Bone Marrow Transplant. 2012 Feb;47(2):291-3. doi: 10.1038/bmt.2011.42. Epub 2011 Mar 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antiemetics / pharmacology*
  • Aprepitant
  • Drug Interactions
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Male
  • Middle Aged
  • Morpholines / pharmacology*
  • Retrospective Studies
  • Sirolimus / administration & dosage
  • Sirolimus / blood
  • Sirolimus / pharmacokinetics*
  • Tacrolimus / administration & dosage
  • Tacrolimus / blood
  • Transplantation, Homologous
  • Young Adult

Substances

  • Antiemetics
  • Immunosuppressive Agents
  • Morpholines
  • Aprepitant
  • Sirolimus
  • Tacrolimus